Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05124457
PHASE2
DETERMINE: Detemir vs NPH
Sponsor: University of California, Los Angeles
View on ClinicalTrials.gov
Summary
The purpose of the study is to compare rates of neonatal hypoglycemia with maternal NPH vs determir use.
Official title: A Phase 2 Open Label Randomized Controlled Trial Determir Vs Neutral Protamine Hagedorn (NPH) In Pregnant Women: DETERMINE Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
336
Start Date
2022-02-01
Completion Date
2025-06
Last Updated
2023-09-26
Healthy Volunteers
No
Interventions
DRUG
Insulin Detemir
Patients are to receive insulin detemir
DRUG
Insulin NPH
Patients are to receive insulin NPH
Locations (1)
University of California, Los Angeles
Los Angeles, California, United States